Back

The FINO-HF trial: a randomised comparison of finerenone versus spironolactone in patients with heart failure with reduced ejection fraction - biomarker and clinical outcomes

29 August 2026 (08:45 - 08:55)
Organised by: Logo
Congress Presentation Part of: Moving the needle further in HFrEF therapy Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Rafael Rascon Sabido

Mexican Institute of Social Security (IMSS), Veracruz (Mexico)

5 More presentations in this session

Presentation thumbnail
Real-world effectiveness of mineralocorticoid receptor antagonists in heart failure with mildly reduced and preserved ejection fraction: a large southeast asian propensity-weighted cohort study
Doctor P. Amornritvanich (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Efficacy of sacubitril/valsartan on mortality in asymptomatic hypotensive HFrEF: data from the China Cardiovascular Association Database-Heart Failure Center Registry
Doctor Z. Qiu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Superior cardiorenal protection with tirzepatide over dulaglutide in heart failure with preserved ejection fraction: a large-scale propensity score–matched real-world analysis
Doctor I. Zahan (Harefield, GB)
Abstract Slides
Presentation thumbnail
The LIRA-HF trial: liraglutide in heart failure with reduced ejection fraction and obesity – a 30-month randomized trial
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract Slides
Presentation thumbnail
Glucagon-like peptide-1 receptor agonism in heart failure with improved ejection fraction; PRAISE-HFiEF
Assistant Professor I. Helmy (Cleveland, US)
Abstract Slides

Access the full session

Session thumbnail
Moving the needle further in HFrEF therapy
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 08:45 CET
You may be interested in
thumbnail
Congress Presentation
Finerenone in the treatment of cardiac failure in patients with hypertrophic cardiomyopathy
31 August 2025
thumbnail
Congress Presentation
Mineralocorticoid receptor antagonists after acute myocardial infarction in patients with mild to moderately reduced ejection fraction
22 May 2023
thumbnail
Congress Presentation
Optimizing spironolactone dosing for initial treatment success in acute decompensated heart failure: a comparative efficacy study
21 March 2026
thumbnail
Congress Presentation
Non-steroidal MRAs in heart failure and cardio-kidney-metabolic disease: current clinical trial evidence
10 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources